If you need to lose in excess of 15 pounds, consider the medically-supervised weight loss program
Are you sure your numbers are correct
William Seeds explains what is happening in his book Peptide Protocols Volume 1: [AOD-9604] is unable to induce dimerization and thereby activation of the receptor (no competition with HGH) This fragment holds the fat-reducing and tissue repair sequence and mimics the effect of HGH on lipid metabolism, without having growth-promoting or pro-diabetic effects [AOD-9604] inhibits lipoprotein lipase activity in adipose tissue, stimulating lipolysis in adipocytes Since AOD-9604 does not interact with growth hormone receptors, it means the peptide has the following advantages over HGH: Does not increase IGF-1 production Does not induce insulin resistance Does not stimulate muscle growth Since beta-3-adrenergic receptor activation appears to be a secondary mechanism of the AOD-9604 peptide, its primary and complete mechanism for fat mobilization and/or fat cell death within adipose tissue is not currently known

The ideal frequency really depends on your individual health needs and how your body responds
In most clinical settings, the peptide is studied via small subcutaneous injections, usually administered in the morning on an empty stomach to maximize the fat-burning signal
Oral tirzepatide complete guide discusses the challenges of delivering peptides through the GI tract